Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

Market Cap	7.03B -17.7%
Revenue (ttm)	3.05B +3.6%
Net Income	469.00M -7.7%
EPS	0.92 -8.4%
Shares Out	494.11M
PE Ratio	15.52
Forward PE	11.61
Dividend	0.31 (2.17%)
Ex-Dividend Date	May 26, 2025

Volume	7,160,464
Average Volume	6,902,920
Open	14.20
Previous Close	14.39
Day's Range	14.16 - 14.47
52-Week Range	13.21 - 20.66
Beta	0.13
RSI	46.22
Earnings Date	Apr 25, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,221
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300705

Financial Performance

In 2024, SHE:300705's revenue was 2.93 billion, an increase of 8.85% compared to the previous year's 2.69 billion. Earnings were 512.38 million, an increase of 39.13%.